Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Enrollment begins in phase II trial of CYT-107 in chronic HIV infection

Sep. 22, 2010

EMA updates nevirapine label for patients with HIV-1 infection

Sep. 21, 2010

Promising phase Ib/IIa data on OBP-601 in HIV

Sep. 15, 2010

Mymetics' HIV vaccine to enter preclinical study in primates

Sep. 13, 2010

Johnson & Johnson submits MAA to EMA for TMC-278 for HIV infection

Sep. 6, 2010

Identification of HIV integrase inhibitor BMS-727740 described by Bristol-Myers Squibb

Aug. 30, 2010

CCR5 gene disruption by SB-728 in HSPCs may be new approach to treat HIV/AIDS

Aug. 24, 2010

Merck & Co. claims new HIV integrase inhibitors

Aug. 24, 2010

Tenofovir vaginal gel reduces risk of HIV infection in women

Aug. 16, 2010

Crucell, IAVI and BIDMC to conduct phase I AdVac-based AIDS vaccine trial

Aug. 12, 2010

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...